Monolitum Flas (Lansoprazole)

Lansoprazole, the active ingredient in Monolitum Flas, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid secretion and is used to treat conditions such as gastro‑oesophageal reflux disease, peptic ulcer disease and to aid eradication of Helicobacter pylori infection.

GNH USA supplies Monolitum Flas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance and timely delivery to customers.

Lansoprazole is a proton pump inhibitor that reduces gastric acid production, making it useful for several acid‑related gastrointestinal conditions.

- Gastro‑oesophageal reflux disease (GERD): decreases acid exposure and promotes healing of esophageal irritation. - Peptic ulcer disease: facilitates ulcer healing by maintaining a higher gastric pH. - NSAID‑induced ulcer prevention: protects the gastric mucosa in patients taking non‑steroidal anti‑inflammatory drugs. - Helicobacter pylori eradication regimens: enhances the effectiveness of antibiotic combinations used to eradicate H. pylori infection.

Lansoprazole may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Headache: mild headache may occur. - Diarrhea: loose stools are reported. - Nausea: feeling of sickness. - Abdominal pain: discomfort in the stomach area. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Severe allergic reaction: anaphylaxis, rash, or swelling. - Clostridioides difficile infection: severe colitis risk. - Low magnesium levels: hypomagnesemia causing muscle cramps. - Liver enzyme elevation: signs of hepatitis. - Interstitial nephritis: inflammation of kidney tissue.

When prescribing or dispensing lansoprazole, several precautionary measures should be observed to ensure patient safety.

- Assess renal function: adjust use in severe renal impairment. - Monitor for infection: be aware of increased risk of Clostridioides difficile colitis. - Review concomitant medications: avoid use with drugs that require acidic pH for absorption. - Use caution in pregnancy: limited data, weigh benefits against potential risks. - Store at room temperature: keep in the original container, protect from moisture.

Lansoprazole can affect the plasma concentrations of several medicines; some combinations should be avoided while others require monitoring.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir: decreased absorption and efficacy. - Methotrexate: increased toxicity, especially at high doses.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR. - Digoxin: may raise serum levels. - Diazepam: potential for increased sedation.